MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Abdominal Neoplasms

(UMLS:C0000735)

Definition:: New abnormal growth of tissue in the ABDOMEN.
UMLS ID:: C0000735
MeSH ID:: D000008

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.588.033

Synonym(s)

Abdominal Neoplasms

ABDOMEN TUMOR

Abdomen--Tumors

Abdominal neoplasm

Abdominal tumor

Neoplasm of abdomen

Tumor of abdomen

Tumour of abdomen

abdomen neoplasm

10.

abdomen tumors

11.

abdomen tumours

12.

abdominal neoplasm

13.

abdominal tumor

14.

abdominal tumors

15.

abdominal tumours

16.

abdominals tumors

17.

tumor abdomen

18.

tumor abdominal

19.

tumor of abdomen

Associated Drug(s)

	Name	Reference(s)	Data Source
1	CVD protocol	12657240	CTD
2	Sulindac	14745880	CTD
3	Tamoxifen	14745880	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Head and Neck Neoplasms	42.9%
2	Soft Tissue Neoplasms	42.9%
3	Thoracic Neoplasms	42.9%
4	Digestive System Neoplasms	30%
5	Endocrine Gland Neoplasms	30%
6	Eye Neoplasms	30%
7	Nervous System Neoplasms	30%
8	Bone neoplasms	28.6%
9	Skin Neoplasms	28.6%
10	Hematologic Neoplasms	28.6%
11	Splenic Neoplasms	27.9%
12	Acanthoma	25.8%
13	Parathyroid Neoplasms	25%
14	Thyroid Neoplasm	25%
15	Thyroid carcinoma	25%
16	Hamartoma	23.1%
17	Neoplasms, Hormone-Dependent	23.1%
18	Neoplasms, Multiple Primary	23.1%
19	Paraneoplastic Syndromes	23.1%
20	Precancerous Conditions	23.1%
21	Neoplasms, Second Primary	23.1%
22	Paraneoplastic Encephalomyelitis	22.8%
23	Tracheal Neoplasms	22.8%
24	Mammary Neoplasms, Experimental	22.2%
25	Mouth Neoplasms	20.9%
26	Pancreatic Neoplasm	20.9%
27	Central Nervous System Neoplasms	20.9%
28	Vascular Neoplasms	20.9%
29	Thymus Neoplasms	20.9%
30	Genital Neoplasms, Female	20.5%
31	Breast Neoplasms, Male	20.2%
32	Triple Negative Breast Neoplasms	20.2%
33	Thyroid Nodule	20%
34	Multiple Endocrine Neoplasia	19.8%
35	Esophageal Neoplasms	18.4%
36	Carcinoma, Lobular	18.2%
37	Thymoma	17.6%
38	Meningioma	16.9%
39	Meningeal Neoplasms	16.9%
40	Testicular Neoplasms	15.9%
41	Carcinoma, Pancreatic Ductal	15.9%
42	Adrenal Gland Neoplasms	15.8%
43	Gastrointestinal Neoplasms	15.8%
44	Genital Neoplasms, Male	15.8%
45	Liver neoplasms	15.8%
46	Uveal Neoplasms	15.8%
47	Urologic Neoplasms	15.5%
48	Sebaceous Gland Neoplasms	15.3%
49	Spinal Neoplasms	15.3%
50	Bone Marrow Neoplasms	15.3%
51	Cyst	15%
52	Multiple Endocrine Neoplasia Type 1	15%
53	Neoplastic Processes	15%
54	Neoplastic Syndromes, Hereditary	15%
55	Pregnancy Complications, Neoplastic	15%
56	Carcinoma, Ehrlich Tumor	14.9%
57	Dermoid Cyst	14.9%
58	Carcinoma, Lewis Lung	14.9%
59	Meningeal Carcinomatosis	14.9%
60	Carcinoma 256, Walker	14.8%
61	Neoplasms, Experimental	14.6%
62	insulinoma	14.6%
63	Gastrinoma	14.5%
64	Glucagonoma	14.5%
65	Vipoma	14.3%
66	Erythroplasia	14.3%
67	Follicular cyst	14.3%
68	leukemia	14.3%
69	Mucocele	14.3%
70	Neoplasms, Germ Cell and Embryonal	14.3%
71	Neoplasms, Glandular and Epithelial	14.3%
72	Pilonidal Cyst	14.3%
73	Thyroglossal Cyst	14.3%
74	Synovial Cyst	14.3%
75	Germ Cell Cancer	14.3%
76	Aberrant Crypt Foci	14.3%
77	Leukoplakia, Oral	14.1%
78	Paraneoplastic Cerebellar Degeneration	14%
79	Neuroectodermal Tumors	13.6%
80	Acoustic Neuroma	13.5%
81	Palatal Neoplasms	13.4%
82	Hepatocellular Adenoma	13.3%
83	Neoplasms, Neuroepithelial	13.3%
84	Gliomatosis cerebri	13.3%
85	Ear Neoplasms	13%
86	Eyelid Neoplasms	13%
87	Lung Neoplasms	13%
88	Pleural Neoplasms	13%
89	Liver Neoplasms, Experimental	12.9%
90	Nose Neoplasms	12.9%
91	Brain Neoplasms	12.6%
92	Salivary Gland Neoplasms	12.6%
93	Spinal Cord Neoplasms	12.6%
94	Tongue Neoplasms	12.6%
95	Peritoneal Neoplasms	12.5%
96	melanoma	12.4%
97	Uterine Neoplasms	12.4%
98	Vaginal Neoplasms	12.4%
99	Vulvar Neoplasms	12.4%
100	Uterine Cancer	12.4%
101	Leydig Cell Tumor	12.4%
102	Carcinosarcoma	12.4%
103	Hemangiosarcoma	12.4%
104	Leukemia L1210	12.4%
105	Leukemia P388	12.4%
106	lymphangiosarcoma	12.4%
107	Fallopian Tube Neoplasms	12.3%
108	Trophoblastic Neoplasms	12.1%
109	Retinoblastoma	12%
110	Leukemia, Experimental	12%
111	Medulloblastoma	11.9%
112	Melanoma, Experimental	11.8%
113	Sarcoma 180	11.7%
114	Limbic Encephalitis	11.6%
115	Optic Nerve Glioma	11.5%
116	Bronchial Neoplasms	11.5%
117	Adenoma, Acidophil	11.5%
118	Ganglioneuroma	11.5%
119	Glioma	11.5%
120	Malignant Glioma	11.5%
121	Multiple Pulmonary Nodules	11.3%
122	Pituitary Adenoma	11.2%
123	Pituitary Neoplasms	11.2%
124	Basal cell carcinoma	11.1%
125	Carcinoma, Papillary	11.1%
126	Squamous cell carcinoma	11.1%
127	Chondrosarcoma	11.1%
128	Craniopharyngioma	11.1%
129	Cystadenoma	11.1%
130	leiomyosarcoma	11.1%
131	liposarcoma	11.1%
132	Mesothelioma	11.1%
133	Supratentorial Neoplasms	11.1%
134	synovial sarcoma	11.1%
135	Neuroectodermal Tumor, Melanotic	11.1%
136	Angiomyolipoma	11.1%
137	Clear Cell Sarcoma of Soft Tissue	11.1%
138	Alveolar Soft Part Sarcoma	11.1%
139	Neuroendocrine Tumors	11.1%
140	Sarcoma, Myeloid	11.1%
141	Carcinoma, Basal Cell	11.1%
142	Carcinoid Tumor	11%
143	Endometrial Neoplasms	11%
144	Neurilemmoma	11%
145	Hutchinson's Melanotic Freckle	11%
146	Melanoma, Amelanotic	11%
147	Sarcoma, Experimental	11%
148	Prolactinoma	11%
149	Growth Hormone-Secreting Pituitary Adenoma	11%
150	Neoplasms, Radiation-Induced	10.8%
151	Astrocytoma	10.6%
152	Ependymoma	10.6%
153	oligodendroglioma	10.6%
154	Ganglioglioma	10.6%
155	gliosarcoma	10.6%
156	Anaplastic astrocytoma	10.6%
157	Anaplastic Oligodendroglioma	10.6%
158	Cystadenocarcinoma	10.5%
159	Fibrosarcoma	10.5%
160	Osteosarcoma	10.5%
161	Mucoepidermoid Carcinoma	10.5%
162	Pharyngeal Neoplasms	10.5%
163	Brain Stem Neoplasms	10.4%
164	Adenoma	10.3%
165	Ameloblastoma	10.3%
166	Angiokeratoma	10.3%
167	Carcinoma	10.3%
168	Chordoma	10.3%
169	Hemangioma	10.3%
170	hemangiopericytoma	10.3%
171	Lymphangioma	10.3%
172	Malignant Carcinoid Syndrome	10.3%
173	Mesenchymoma	10.3%
174	Nevus	10.3%
175	Teratoma	10.3%
176	Hepatoblastoma	10.3%
177	Mixed Tumor, Mullerian	10.3%
178	Germinoma	10.3%
179	Teratocarcinoma	10.3%
180	Angiofibroma	10.3%
181	Sarcoma	10.3%
182	Epithelioma	10.3%
183	Choriocarcinoma	10.2%
184	Central Nervous System Cysts	10.2%
185	Adenofibroma	10.2%
186	Fibroadenoma	10.2%
187	Malignant Fibrous Histiocytoma	10.2%
188	Lambert-Eaton Myasthenic Syndrome	10.1%
189	Glioblastoma	10.1%
190	Neuroblastoma	10.1%
191	Glioblastoma Multiforme	10.1%
192	Nephroblastoma	10.1%
193	ovarian neoplasm	10.1%
194	Bile Duct Neoplasms	10.1%
195	gallbladder neoplasm	10.1%
196	Intestinal Neoplasms	10.1%
197	Penile Neoplasms	10.1%
198	Prostatic Neoplasms	10.1%
199	Stomach Neoplasms	10.1%
200	Choroid Plexus Papilloma	10%
201	Ganglioneuroblastoma	9.9%
202	Bowen's Disease	9.9%
203	Paraganglioma	9.9%
204	Rhabdomyosarcoma	9.9%
205	Giant Cell Tumor of Bone	9.9%
206	Polycythemia Vera	9.9%
207	Adrenocortical carcinoma	9.8%
208	Leukemia, Radiation-Induced	9.7%
209	Dermatofibrosarcoma	9.6%
210	Dermatofibrosarcoma Protuberans	9.6%
211	Leukoplakia	9.5%
212	Lymphocele	9.5%
213	Pancreatic Cyst	9.5%
214	granulosa cell tumor	9.3%
215	Carcinoma, Ovarian Epithelial	9.3%
216	Barrett Esophagus	9.3%
217	Breast Cyst	9.3%
218	Histiocytic Disorders, Malignant	9.3%
219	Actinic keratosis	9.3%
220	Mediastinal Cyst	9.3%
221	Neoplasm Invasiveness	9.3%
222	Neoplasm Metastasis	9.3%
223	Neoplasm Recurrence, Local	9.3%
224	Parovarian Cyst	9.3%
225	Pericardial Cyst	9.3%
226	Thymic Cyst	9.3%
227	Carcinogenesis	9.3%
228	Myxoid cyst	9.3%
229	Metastasis	9.3%
230	Pheochromocytoma	9.3%
231	Alveolar rhabdomyosarcoma	9.3%
232	Leukemia, Plasma Cell	9.2%
233	Mesoblastic Nephroma	9.1%
234	Hypopharyngeal Neoplasms	9%
235	Pleural Effusion, Malignant	9%
236	Hypopharyngeal Cancer	9%
237	Parotid Neoplasms	8.9%
238	Prostatic Neoplasms, Castration-Resistant	8.9%
239	Opsoclonus-Myoclonus Syndrome	8.8%
240	Nelson Syndrome	8.8%
241	Laryngeal neoplasm	8.8%
242	Adenocarcinoma	8.5%
243	Carcinoma in Situ	8.5%
244	Carcinoma, Transitional Cell	8.5%
245	Phyllodes Tumor	8.5%
246	Dysgerminoma	8.5%
247	Hemangioendothelioma	8.5%
248	Lipoma	8.5%
249	Myoma	8.5%
250	Myxoma	8.5%
251	Neuroma	8.5%
252	Papilloma	8.5%
253	Pseudomyxoma Peritonei	8.5%
254	Seminoma	8.5%
255	Papillomatosis	8.5%
256	Angiolipoma	8.5%
257	Myelolipoma	8.5%
258	Neoplasms, Bone Tissue	8.5%
259	Neoplasms, Fibrous Tissue	8.5%
260	Smooth Muscle Tumor	8.5%
261	Adenomatosis, Pulmonary	8.5%
262	Adenomatous Polyps	8.5%
263	Carcinoma, Large Cell	8.5%
264	Carcinoma, Small Cell	8.5%
265	Desmoplastic Small Round Cell Tumor	8.5%
266	Chondroma	8.5%
267	Enchondroma	8.5%
268	Tonsillar Neoplasms	8.3%
269	Renal Cell Carcinoma	8.3%
270	Papillary Renal Cell Carcinoma	8.3%
271	Cerebellar Neoplasms	8.3%
272	Bladder Neoplasm	8.3%
273	Kidney Neoplasm	8.3%
274	Ureteral Neoplasms	8.3%
275	Urethral Neoplasms	8.3%
276	Lymphomatoid Granulomatosis	8.3%
277	Adenomatous Polyposis Coli	8.2%
278	Tuberous Sclerosis	8.2%
279	Carcinoid Heart Disease	8.2%
280	Composite Lymphoma	8%
281	Carcinoma, Endometrioid	7.9%
282	Hydatidiform Mole	7.8%
283	Myelitis, Transverse	7.7%
284	Adenoid Cystic Carcinoma	7.6%
285	fibroma	7.6%
286	Fibromatosis	7.6%
287	Osteoblastoma	7.6%
288	Osteoma	7.6%
289	Rhabdomyoma	7.6%
290	Chondromatosis	7.6%
291	Adenocarcinoma, Clear Cell	7.6%
292	Cholangiocarcinoma	7.6%
293	Cervical Intraepithelial Neoplasia	7.6%
294	Hemangioblastoma	7.6%
295	Lymphoma, Extranodal NK-T-Cell	7.6%
296	Cecal Neoplasms	7.4%
297	Duodenal Neoplasms	7.4%
298	Nasopharyngeal carcinoma	7.2%
299	Neurofibrosarcoma	7.1%
300	Fibromatosis, Aggressive	7.1%
301	Fibromatosis, Abdominal	7.1%
302	Klatskin Tumor	7.1%
303	Basal Cell Nevus Syndrome	7.1%
304	Lymphoma	6.9%
305	Appendiceal Neoplasms	6.9%
306	Colonic Neoplasms	6.9%
307	Rectal Neoplasms	6.9%
308	Endometrial Stromal Sarcoma	6.9%
309	Pancreatic Pseudocyst	6.8%
310	Plasmacytoma	6.8%
311	Corpus Luteum Cyst	6.8%
312	Ovarian Cysts	6.8%
313	Malignant histiocytosis	6.7%
314	Lymphatic Metastasis	6.7%
315	Neoplasms, Unknown Primary	6.7%
316	Leukemic Infiltration	6.7%
317	Histiocytic sarcoma	6.7%
318	Neoplasm Micrometastasis	6.7%
319	Lymphangioleiomyomatosis	6.6%
320	Nasopharyngeal Neoplasms	6.4%
321	Colorectal Neoplasms	6.3%
322	Denys-Drash Syndrome	5.9%
323	Anus Neoplasms	5.7%
324	Sigmoid Neoplasms	5.7%
325	Paranasal Sinus Neoplasms	5.6%
326	Choledochal Cyst	5.6%
327	Leukemia, Myelomonocytic, Chronic	5.6%
328	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	5.6%
329	Peutz-Jeghers Syndrome	5.4%
330	Maxillary Sinus Neoplasms	5.2%
331	Mastocytoma	5%
332	Hodgkin Disease	5%
333	Lymphoma, Non-Hodgkin	5%
334	Mastocytosis, Systemic	5%
335	Polycystic Ovary Syndrome	5%
336	Leukemia, Myeloid, Chronic-Phase	4.9%
337	Mastocytosis	4.3%
338	Sturge-Weber Syndrome	4.3%
339	Cell Transformation, Viral	4.2%
340	Gastrointestinal Stromal Tumors	4.2%
341	Hemangioma, Cavernous	4.2%
342	Leukemia, T-Cell	4.1%
343	Leukemia, B-Cell	4.1%
344	neurofibroma	4.1%
345	Lymphoma, Follicular	4.1%
346	T-Cell Lymphoma	4.1%
347	Mantle cell lymphoma	4.1%
348	Primary amyloidosis	4%
349	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
350	Leukemia, Large Granular Lymphocytic	3.7%
351	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
352	Lymphoma, T-Cell, Cutaneous	3.7%
353	Lymphoma, AIDS-Related	3.7%
354	Enteropathy-Associated T-Cell Lymphoma	3.7%
355	Primary Effusion Lymphoma	3.7%
356	Dupuytren Contracture	3.6%
357	Urticaria Pigmentosa	3.5%
358	Mycosis Fungoides	3.4%
359	Lymphomatoid Papulosis	3.4%
360	Plasmablastic lymphoma	3.4%
361	Xeroderma Pigmentosum	3%
362	Waldenstrom Macroglobulinemia	2.9%
363	Multiple Myeloma	2.9%
364	Zollinger-Ellison syndrome	2.5%
365	Burkitt Lymphoma	2.4%
366	Sezary Syndrome	2.3%
367	Radicular Cyst	2.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234